| Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845) |
|---|
| 02/05/2004 | US20040024202 C-17 spirolactonization and 6,7 oxidation of steroids |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 02/04/2004 | EP1385527A1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
| 02/04/2004 | CN1473164A Process for production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21- dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/27/2004 | CA2115015C Process for the preparation of 6alpha,9alpha-difluorinated steroids and novel intermediates obtained thereby |
| 01/22/2004 | US20040014735 11-Beta substituted 19-nor-17-alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/15/2004 | WO2004005314A1 ESTRIENO[3,2-b]/[3,4-c]PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS |
| 01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
| 01/15/2004 | CA2491132A1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
| 01/14/2004 | CN1468086A Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 01/13/2004 | US6677329 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 01/08/2004 | WO2004002504A1 Plant extracts |
| 01/07/2004 | CN1466592A 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 01/07/2004 | CN1133645C Antineoplastic compound intercedenside A |
| 01/02/2004 | EP1375509A1 Use of a sapogenin, or a natural extract containing the same, for the treatment of oligoseborrheic dry skin |
| 01/02/2004 | EP1373298A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 01/01/2004 | US20040002484 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/31/2003 | WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives |
| 12/31/2003 | WO2003047329A3 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 12/31/2003 | CN1132841C Total triterpenoid saponin in coral ardisa root or other plants in same family and preparing process thereof |
| 12/30/2003 | US6670347 Selective estrogens that show preference for one of the two known estogen receptors |
| 12/17/2003 | CN1131236C Process for puification of 11beta-21-dihydroxy-2'-5' beta H-pregna-1,4-dieno [17.16-D] oxazole-3,20-dione |
| 12/11/2003 | US20030229061 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/10/2003 | EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 12/10/2003 | CN1460685A Method for synthesizing sechuded chamber saponin |
| 12/09/2003 | CA2150233C Process for producing provitamin d compound |
| 12/04/2003 | WO2003070194A3 Amino acid and peptide-modified forms of glucocorticoids |
| 12/04/2003 | WO2002030462A3 Hedgehog antagonists, methods and uses related thereto |
| 12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
| 11/27/2003 | WO2002062302A3 Steroidal derivatives |
| 11/26/2003 | EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 11/26/2003 | CN1458164A Purifying technology for lipid bufalin genin and cino-bufagin in fresh senso |
| 11/20/2003 | WO2003082896A3 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS |
| 11/20/2003 | WO2003070745A3 Carbonate and carbamate modified forms of glucocorticoids |
| 11/20/2003 | US20030216328 Androgen derivatives and uses thereof |
| 11/20/2003 | US20030216327 Sapogenin-based treatment |
| 11/19/2003 | CN1456571A Synthesis of diosgenin-3-beta-cellobiaside |
| 11/19/2003 | CN1456570A Extraction of saponin from seeds of trigonella foenum-graecum |
| 11/13/2003 | WO2003092578A2 Further syntheses of cyproterone acetate |
| 11/13/2003 | CA2482997A1 Further syntheses of cyproterone acetate |
| 11/05/2003 | EP1359154A1 Further syntheses of cyproterone acetate |
| 11/05/2003 | CN1453290A Prepn of curcumol and oral medicine containing curcumol |
| 10/30/2003 | WO2003047329A8 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 10/29/2003 | CN1452630A Substd. sapogenins and their use |
| 10/29/2003 | CN1451665A Carboxylic derivs. of diosgenin and process for preparing same |
| 10/23/2003 | US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 10/22/2003 | CN1450082A Process for extracting dioscin from yellow ginger and Rhizoma Dioscoreae Nipponicae and producing organic fertilizer using residue of same |
| 10/21/2003 | US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias |
| 10/16/2003 | US20030195182 Triterpene derivatives and remedies for liver diseases |
| 10/09/2003 | WO2003082896A2 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS |
| 10/09/2003 | WO2003082895A2 Process to prepare eplerenone |
| 10/09/2003 | WO2003082894A2 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | WO2003082893A2 Theraputic methods and uses of sapogenins and their derivatives |
| 10/09/2003 | US20030190299 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 10/09/2003 | US20030190289 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases |
| 10/09/2003 | CA2480629A1 A process for the preparation of 6.alpha.-fluoro steroids by isomerisation of 6.beta.-fluorosteroids |
| 10/09/2003 | CA2480151A1 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | CA2474072A1 Process to prepare eplerenone |
| 10/08/2003 | EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 10/08/2003 | CN1446820A Technique for extracting improved tigogenin |
| 10/07/2003 | US6630587 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/07/2003 | US6630453 Androgen derivatives and uses thereof |
| 10/02/2003 | WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 10/02/2003 | WO2003080067A1 3-0-'alfa-l-rhamnopyranosyl- (1-2) -alpha-l-rhamnopyranosyl- (1-4) -3beta-d-glucopyranosyl!-25 (s) -spirost an-3beta-ol, process for its isolation, and its use as immunomodulator |
| 09/24/2003 | CN1444596A 16 alpha-methyl or ethyl substituted estrogens |
| 09/18/2003 | US20030176407 Carbonate and carbamate modified forms of glucocorticoids |
| 09/17/2003 | CN1442484A Production method of diosgenin |
| 09/12/2003 | WO2003074545A1 METHOD FOR SYNTHESIZING 5ß, 6ß-EPOXIDES OF STEROIDS BY A HIGHLY ß-SELECTIVE EPOXIDATION OF Δ5-UNSATURATED STEROIDS CATALYZED BY KETONES |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/10/2003 | CN1440979A Steroid saponin from sealwort as Chinese medicine material and its medicinal use and prepn process |
| 09/10/2003 | CN1120844C Lactone compound and its synthesis and use |
| 09/04/2003 | WO2002009760A9 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 09/03/2003 | EP1339734A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP1339733A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 08/28/2003 | WO2003070745A2 Carbonate and carbamate modified forms of glucocorticoids |
| 08/28/2003 | WO2003070194A2 Amino acid and peptide-modified forms of glucocorticoids |
| 08/28/2003 | US20030162959 Reacting 17-hydroxy-9 beta ,11 beta -epoxy-16- beta -methyl-pregna-1,4-diene-3,20-dione 21-acetate compound with a stereoselective fluorinating agent to stereoselectively form a 21-ester, 17-hydroxy 6 alpha -fluorinated compound |
| 08/28/2003 | US20030162759 Preventing or treating cardiovascular disease including atherosclerosis |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/26/2003 | US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative |
| 08/21/2003 | US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 08/21/2003 | US20030158161 Administering to the human patient or non- human animal an effective amount of a substituted spirostan derivative to treat neurodegenerative disorders |
| 08/20/2003 | EP1335929A1 Process for the production of 16,17- (cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
| 08/14/2003 | WO2003066656A1 Crystalline complexes of fluticasone 2-furoate |
| 08/14/2003 | WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | WO2003066032A1 Formulations for inhalation |
| 08/14/2003 | WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 08/14/2003 | WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/14/2003 | US20030153542 Novel anti-inflammatory androstane derivative compositions |
| 08/13/2003 | EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 08/06/2003 | CN1434040A Medicine with 1,6-methylene-[10]-annulene difuran and steroid basic structure and use thereof |
| 07/31/2003 | WO2003062260A1 Triterpene quaternary salts as biologically active surfactants |
| 07/31/2003 | WO2003045971A3 Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof |
| 07/31/2003 | CA2473799A1 Triterpene quaternary salts as biologically active surfactants |
| 07/30/2003 | EP1330999A1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 07/30/2003 | EP1330468A1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |